QuidelOrtho to Participate in the Baird 2025 Global Healthcare Conference
QuidelOrtho (NASDAQ: QDEL), a global provider of in vitro diagnostic technologies, announced its participation in the upcoming Baird 2025 Global Healthcare Conference. The company's management team will engage in a fireside chat on September 10, 2025, at 3:10 p.m. ET.
Investors and interested parties can access the live webcast and replay through QuidelOrtho's investor relations website. The company specializes in diagnostic solutions for point-of-care settings, clinical laboratories, and transfusion medicine.
QuidelOrtho (NASDAQ: QDEL), fornitore mondiale di tecnologie diagnostiche in vitro, ha annunciato la sua partecipazione al Baird 2025 Global Healthcare Conference. Il team di dirigenti dell'azienda parteciperà a una fireside chat il 10 settembre 2025 alle 15:10 ET.
Investitori e interessati potranno seguire la diretta e la replica tramite il sito web per gli investitori di QuidelOrtho. L'azienda è specializzata in soluzioni diagnostiche per il punto di cura, i laboratori clinici e la medicina trasfusionale.
QuidelOrtho (NASDAQ: QDEL), proveedor global de tecnologías de diagnóstico in vitro, anunció su participación en la Baird 2025 Global Healthcare Conference. El equipo directivo de la compañía participará en una charla informal el 10 de septiembre de 2025 a las 3:10 p.m. ET.
Los inversores y demás interesados podrán acceder a la transmisión en vivo y a la repetición a través del sitio web de relaciones con inversores de QuidelOrtho. La compañía se especializa en soluciones diagnósticas para entornos de atención en el punto de atención, laboratorios clínicos y medicina transfusional.
QuidelOrtho (NASDAQ: QDEL), 체외 진단 기술의 글로벌 공급업체가 다가오는 Baird 2025 Global Healthcare Conference에 참여한다고 발표했습니다. 회사 경영진은 2025년 9월 10일 오후 3시 10분(동부 표준시)에 파이어사이드 채팅에 참여합니다.
투자자 및 관심 있는 사람들은 QuidelOrtho 투자자 관계 웹사이트를 통해 생중계 및 다시 보기를 이용할 수 있습니다. 회사는 현장(point-of-care) 진단, 임상 실험실 및 수혈 의학을 위한 진단 솔루션을 전문으로 합니다.
QuidelOrtho (NASDAQ: QDEL), fournisseur mondial de technologies de diagnostic in vitro, a annoncé sa participation à la Baird 2025 Global Healthcare Conference. L'équipe dirigeante de la société prendra part à une discussion informelle le 10 septembre 2025 à 15h10 ET.
Les investisseurs et les personnes intéressées peuvent accéder à la retransmission en direct et au replay via le site investisseurs de QuidelOrtho. L'entreprise est spécialisée dans les solutions diagnostiques pour les points de soins, les laboratoires cliniques et la médecine transfusionnelle.
QuidelOrtho (NASDAQ: QDEL), ein weltweit tätiger Anbieter von In-vitro-Diagnostiktechnologien, kündigte seine Teilnahme an der Baird 2025 Global Healthcare Conference an. Das Managementteam des Unternehmens wird am 10. September 2025 um 15:10 Uhr ET an einem Fireside-Chat teilnehmen.
Investoren und Interessierte können das Live-Webcast und die Aufzeichnung über die Investor-Relations-Website von QuidelOrtho abrufen. Das Unternehmen ist auf diagnostische Lösungen für Point-of-Care, klinische Labore und Transfusionsmedizin spezialisiert.
- None.
- None.
Interested parties can access the live webcast and replay in the "Events & Presentations" section of the "Investor Relations" page of QuidelOrtho's website at https://ir.quidelortho.com.
QuidelOrtho is dedicated to advancing diagnostics to power a healthier future. For more information, please visit quidelortho.com and follow QuidelOrtho on LinkedIn, Facebook and X.
About QuidelOrtho Corporation
QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in vitro diagnostics, developing and manufacturing intelligent in vitro diagnostics solutions that transform data into understanding and action for more people in more places every day.
By offering industry-leading expertise in immunoassay and molecular testing, clinical chemistry and transfusion medicine, QuidelOrtho brings fast, accurate and reliable diagnostics when and where they are needed – from home to hospital, lab to clinic.
Building on its long history of innovation, QuidelOrtho works with global healthcare customers to advance diagnostics, where insights and solutions seamlessly connect, illuminating a clearer path for informed decisions.
Investor Contact:
Juliet Cunningham
Vice President, Investor Relations
IR@quidelortho.com
Media Contact:
D. Nikki Wheeler
Senior Director, Corporate Communications
media@quidelortho.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/quidelortho-to-participate-in-the-baird-2025-global-healthcare-conference-302540601.html
SOURCE QuidelOrtho Corporation
FAQ
When is QuidelOrtho (QDEL) presenting at the Baird 2025 Global Healthcare Conference?
How can investors access QuidelOrtho's (QDEL) presentation at the Baird conference?
What type of products does QuidelOrtho (QDEL) specialize in?
What format will QuidelOrtho's (QDEL) presentation take at the Baird Healthcare Conference?
